The table below shows Adicet Bio, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$21.49M
-$25.40M
-$22.85M
-$24.09M
$4.11M
-$15.15M
Capital expenditure
$37.00K
$1.49M
$239.00K
$1.92M
$2.63M
$658.00K
Investing cash flow
$18.88M
-$2.86M
-$239.00K
-$1.92M
-$2.63M
$7.84M
Dividends paid
-
-
-
-
ACET operating cash flow (10-K history)
Adicet Bio, Inc. reported operating cash flow of -$95.25M for fiscal year 2025. That is down 3.1% from -$92.38M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$10.98M (FY 2017) to -$95.25M. Figures come from the company's audited annual reports as filed with the SEC.